CHENGDU, China, June 13, 2025 /PRNewswire/ -- On June 12, Keymed Biosciences Inc. (HKEX: 02162) announced that Prof. Jun Shi's research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of...
Read More Details
Finally We wish PressBee provided you with enough information of ( Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine )
Also on site :